Breaking AI & Tech News Analyzed

The UK's Stem Cell Transplant System Under Scrutiny The UK's stem cell transplant system is potentially putting the lives of blood cancer patients at risk as a result of inadequate infrastructure and a lack of long-term planning, a parliamentary report has found. The Critical Role of Stem Cell Transplants A hematopoietic stem cell transplant, often referred to as a bone marrow transplant, is a medical procedure in which stem cells from a healthy donor are transplanted into a patient. It can be a life-saving treatment for serious diseases such as blood cancer, blood disorders and some auto-immune conditions. About 4,000 stem cell transplants are performed in the UK each year. The Report's Key Findings The report, by the all-party parliamentary group on ethnicity transplantation and transfusion, found that the UK's stem cell transplant system was not fit for purpose, with the system 'no longer resilient, sustainable nor equitable' or meeting patients' needs. In 2024-25, only 24% of stem cell transplants in the UK used a UK donor, compared to the UK Stem Cell Strategic Forum expert group's recommendation of 45%. Stem cell donations from overseas cost more than those from UK donors, while also introducing supply chain risks. People from minority backgrounds have only a 37% chance of getting a well-matched donor compared with 72% of white patients from a northern European background. Health Inequalities and Call for Action The review also found that people from minority-ethnic backgrounds who needed a stem cell transplant faced significant health inequalities. The APPG has recommended that the government launches a review into the UK's stem cell system to address the issues. Bell Ribeiro-Addy, Labour MP and chair of the APPG, said: 'This report raises urgent questions about whether the UK's stem cell transplant system is truly fit for the future.' Recommendations and Future Outlook Campaigners and charities have welcomed the report's findings and recommendations, calling for action to address the inequalities in access to stem cell transplants for people from minority ethnic backgrounds.